Aisulu Gainutdin

Aisulu Gainutdin

Auto-generated profile, based on publicly available information

Aisulu Gainutdin

Department of Gastroenterology, Asfendiyarov Kazakh National Medical University, Almaty, Republic of Kazakhstan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2023 in BULLETIN OF SURGERY IN KAZAKHSTAN
Verified
Journal Article
Closed access
AGA Gainutdin
A Gainutdin
NANazugum Ashimova
Nazugum Ashimova
ANAlexander V Nersesov
Alexander V Nersesov
AIAlpamys Issanov
Alpamys Issanov
TTT Tajibayev
T Tajibayev
ASAlmaty Jsc “A.N. Syzganov National Scientific Center Of Surgery”
Almaty Jsc “A.N. Syzganov National Scientific Center Of Surgery”
Primary biliary cholangitis (PBC, formerly known as primary biliary cirrhosis) is one of the most significant diseases that is predominantly verified in women. The prevalence of PBC is 1.9-40.2 per 100,000 population. Antimitochondrial antibodies (AMA) are of major importance for the diagnosis of primary biliary cirrhosis (PBC), and it has also been suggested that they may be involved in the pathogenesis of the disease. Objective: The aim of this study was to characterize the clinical, biochemical parameters and response to UDCA (Paris I criteria) PBC patients depending on AMA status in the Republic of Kazakhstan. Material and methods. The study was conducted on the basis of the Research Institute of Cardiology and Internal Diseases from 2014 to 2019. A total of 212 patients with primary biliary cholangitis were recorded. Results. Among 212 patients, 171 (80.7%) were AMA-positive and 41(19,3%) - AMA-negative. Vast majority of patients in both groups were Asian (179; 84.4%) and female (206; 97.2%). Severe disease (F3/4) was revealed in 108 (63.2%) AMA-positive and in 18 (43.9 %) AMA-negative patients (p>0.05). AMA-positive and AMA-negative PBC were associated with autoimmune hepatitis in 88 (51.5%) and 10 (24.4%) cases (p0.05). Response to ursodeoxycholic acid (UDCA) treatment according to Paris I criteria was noted in 24 out of 81 (29.6%) AMA-positive and in 9 out of 22 (40.9%) AMA-negative patients (p>0.05). Conclusion. In patients with AMA-positive PBC compared with AMA-negative, there is a statistically significant high value of autoimmune hepatitis and autoimmune thyroiditis. Whereas, response to UDCA treatment according to Paris I criteria is higher in AMA-negative PBC.

22 May 2025 in Journal of Clinical Medicine of Kazakhstan
Verified
Journal Article
Open access
AYArina Yespotayeva
Arina Yespotayeva
KKKairat Kabulbayev
Kairat Kabulbayev
Almagul KurmanovaAlmagul Kurmanova
Almagul Kurmanova
ANAlexander V Nersesov
Alexander V Nersesov
ARAigul Raissova
Aigul Raissova
AGAisulu Gainutdin
Aisulu Gainutdin
Background and aims: Chronic viral hepatitis, including Hepatitis B (HBV) and Hepatitis C (HCV), remains a major health concern among hemodialysis patients. This study analyzes the prevalence and characteristics of HBV and HCV infections in hemodialysis patients treated at a single center in Almaty, focusing on comorbidities such as diabetes, hypertension, and cirrhosis. This study aims to determine the prevalence of these infections among hemodialysis patients in Kazakhstan and assess their associated comorbidities, complications, and overall impact on patient health. Methods: Data from the Almaty Center of Hepatology (2016–2023) served as the basis for the study cohort. Inclusion criteria included CKD stage 5, hemodialysis dependence, ESRD, and confirmed HBV, HCV, or both. The study consists of 164 patients diagnosed with HBV, HCV, or mixed infections, with data collected on demographic distribution, viral genotype prevalence, fibrosis staging, and associated conditions. Results: The findings highlight a substantial prevalence of comorbid conditions in hemodialysis patients with viral hepatitis. The study population includes 95 males (57.9%) and 69 females (42,1%), with a slight male predominance. HCV was the most common infection (76.8%), followed by HBV (14%) and mixed HCV+HBV (9.2%). The high percentage of an unspecified genotype (36.4%) suggests that enhanced diagnostic strategies are needed. Cirrhosis was observed in nearly 90% of the cohort, and 92.7% exhibited ascites. Fibrosis progression was significant, with 25.5% of patients in stage 1, 24.2% in stage 2, and 18.8% in stage 3. The prevalence of hypertension (53.9% with high-risk stage 3 hypertension), diabetes (14.5% with type 2 diabetes), and cirrhosis (89.7%) was assessed. Additionally, hepatitis genotypes were identified, with HCV genotype three being the most common (18.2%) and genotype 1 (17.6%). Conclusions: The results of this study demonstrate that patients on hemodialysis with viral hepatitis represent a particularly vulnerable group with a high incidence of severe liver damage and multiple comorbidities. The high rates of advanced fibrosis, cirrhosis, and associated conditions such as hypertension and diabetes underscore the need for timely diagnosis and complex, patient-centered care

29 October 2026 in Journal of Clinical Medicine of Kazakhstan
Verified
Journal Article
Open access
PDF file
AMArailym Maikenova
Arailym Maikenova
ANAlexander V Nersesov
Alexander V Nersesov
ARAigul Raissova
Aigul Raissova
EKElmira Kuantay
Elmira Kuantay
MAMalika Aznabakiyeva
Malika Aznabakiyeva
NANazugum Ashimova
Nazugum Ashimova
Introduction: Direct-acting antiviral therapy achieves high cure rates in chronic hepatitis C; however, a minority of patients do not achieve a sustained virologic response. The aim of this study was to evaluate clinical, demographic, and virologic factors associated with failure to achieve a sustained virologic response among patients with chronic hepatitis C treated in the Turkestan Region of Kazakhstan. Methods: We performed a retrospective case-control study of 168 adults treated with direct-acting antivirals between January 2018 and December 2022. The control group comprised 126 patients who achieved a sustained virologic response, and the case group comprised 42 patients without a sustained virologic response. Demographic characteristics, disease duration, treatment duration, adherence, hepatitis C virus genotype, pretreatment alanine aminotransferase level, liver elastography, and fibrosis stage were analyzed. Results: Patients without a sustained virologic response had higher pretreatment alanine aminotransferase levels (p=0.03), higher liver stiffness values on elastography (p=0.007), and a longer duration of chronic hepatitis C before treatment (p<0.0001). Genotype 3 was more frequent among cases than controls (59.5% vs 24.6%; p<0.0001), and F4 fibrosis was also more common (40.5% vs 10.3%; p<0.0001). Treatment duration greater than 12 weeks (p=0.02) and lower treatment adherence (p<0.0001) were more frequent in the case group. Age, sex, ethnicity, and previous pegylated interferon/ribavirin therapy did not differ significantly between groups. Conclusion: Failure to achieve a sustained virologic response was associated with greater biochemical activity, more advanced liver fibrosis, longer disease duration, genotype 3 infection, and lower treatment adherence. Adherence represents a potentially modifiable factor that may be addressed through structured follow-up and patient counseling.

1 June 2023 in BULLETIN OF SURGERY IN KAZAKHSTAN
Verified
Journal Article
Closed access
AGA.E. Gainutdin
A.E. Gainutdin
ANAlexander V Nersesov
Alexander V Nersesov
JKJamilya Kaibullayeva
Jamilya Kaibullayeva
ARA.M. Raisova
A.M. Raisova
DSD.S. Suleimenova
D.S. Suleimenova
NAN.ZH. Akmolda
N.ZH. Akmolda
Drug-induced liver injury (DILI) is one of the types of adverse reactions to drugs that occur as a result of their hepatotoxic effect. The pathogenesis of drug-induced autoimmune hepatitis (LIAH) is based on the production of autoantibodies to neoantigens, which are proteins of the cytochrome P450 system, which are the result of the reaction of drug metabolites. A clinically relevant problem, such as drug-induced liver damage, affects 1-1.5 million patients almost every year. The annual incidence of DILI ranges from 2.3-13.9 per 100,000 population in population studies from Europe. The Icelandic population study recorded the highest rates of 19.1 per 100,000 population per year. And in the only study based on the US population, it was found that DILI is approximately 3 per 100,000 population. Acute hepatitis is currently a well-known manifestation, and accounts for more than 90% of liver damage caused by medications. According to studies, 2.9 - 8.8% of DILI and 2 - 18% of AIH are associated with drug-induced autoimmune hepatitis. The incidence of drug-induced liver damage with the presence of antibodies (antibodies to nuclear antigen, smooth muscle and soluble liver antigen) to AIH is 83% for nitrofurantoin, 74% for minocycline, 60% for methyldopa and 43% for hydralazine.

30 June 2025 in Наука и здравоохранение
Verified
Journal Article
Open access
LYL.K. Yerdalieva
L.K. Yerdalieva
AGA.E. Gainutdin
A.E. Gainutdin
ANAlexander V Nersesov
Alexander V Nersesov
ARA.M. Raisova
A.M. Raisova
DSD.S. Suleimenova
D.S. Suleimenova
FNF.N. Nurbekova
F.N. Nurbekova
Relevance: Based on the analysis of the results of videocapsular endoscopy of 84 patients with signs of gastrointestinal pathology and the results of a pathoanatomic examination of biopsy material taken during colonoscopy of the same 84 patients (52 of them have biopsy results), the reliability, features, principles and possibilities of using capsule endoscopy as a research method for diseases of the gastrointestinal tract are determined in the article. Aim: to determine the effectiveness of capsule endoscopy in the diagnosis of gastrointestinal disease. Materials and methods: From 2022 to 2023 84 capsule endoscopy studies (hereinafter referred to as CE) were conducted at the Interna clinic in Almaty. Patient identification data, diagnoses, reasons for examination, and underlying disease were collected. The results of the examination were collected and analyzed, and the results of the pathoanatomical examination of the biopsy material of the same patients were studied, which were conducted by the laboratory of Pathomorphology in the conditions of the A.N. Syzganov National Scientific Center of Surgery JSC. Results: The research material presents the diagnostic capabilities of capsule endoscopy for the detection of diseases of the gastrointestinal tract. Conclusions: Videocapsular endoscopy is a modern, non-invasive and highly informative research method that helps solve many issues of diagnosis and choice of therapeutic tactics in diseases of the small intestine. In Kazakhstan, capsule endoscopic method has been carrying out since 2014 and due to evolving burden of bowel disease worldwide, including Kazakhstan, where the quality of research on capsule endoscopy meets international standards, we undoubtedly consider that further research is needed for its wider introduction into clinical practice. Актуальность: Видеокапсульная эндоскопия является современным, неинвазивным и высокоинформативным методом исследования, который помогает решить многие вопросы диагностики и выбора лечебной тактики при заболеваниях тонкого кишечника. В данной статье показаны диагностические возможности применения капсульной эндоскопии для выявления заболеваний желудочно-кишечного тракта у 84 пациентов и описан клинический случай диагностики и постановки точного диагноза. Цель работы: определение эффективности капсульной эндоскопии в диагностике заболевании ЖКТ. Материалы и методы: С 2022г. по 2023г. В Interna clinic в Алматы было проведено 84 исследовании капсульной эндоскопии (далее КЭ). Собирались идентификационные данные пациентов, диагнозы, причины обследования, основное заболевание. Результаты КЭ были собраны и проанализированы, а также были изучены результаты патологоанатомического исследования биологического материала этих же пациентов, которые были проведены в лаборатории патоморфологии в условиях АО «Национальный научный центр хирургии им. А.Н. Сызганова». Результаты: В исследовательском материале представлены диагностические возможности капсульной эндоскопии для выявления заболевании желудочно-кишечного тракта. Выводы: Качество исследования капсульной эндоскопии соответствует мировым стандартам, но, несомненно, необходимы дальнейшие исследования для более широкого внедрения ее в клиническую практику. В Казахстане капсульный эндоскопический метод применяется с 2014 года, и в связи с растущим распространением заболеваний кишечника во всем мире, включая Казахстан, где качество исследований в области капсульной эндоскопии соответствует международным стандартам, мы, несомненно, считаем, что необходимы дальнейшие исследования для его более широкого внедрения в клиническую практику Өзектілігі: Мақалада асқазан-ішек жолдарының патологиясының белгілері бар 84 пациенттің бейнекапсулалық эндоскопия нәтижелерін және осы 84 пациенттің колоноскопиясы кезінде алынған биопсиялық материалды патологиялық-анатомиялық зерттеу нәтижелерін талдау негізінде (оның 52-сінде биопсия нәтижелері бар) асқазан-ішек жолдарының ауруларында зерттеу әдісі ретінде капсулалық эндоскопияны қолданудың сенімділігі, ерекшеліктері, принциптері мен...